A Rare Inflammatory Disease Better Understood Thanks to a Chinese Study
A rare inflammatory disease better understood thanks to a Chinese study A severe inflammatory disease primarily affecting adult men has just been more thoroughly described by Chinese researchers. This condition, characterized by widespread inflammation, rheumatic symptoms, and blood abnormalities, is distinguished by frequent skin lesions and a particular type of anemia.
Scientists analyzed 57 patients with unexplained inflammation and blood disorders. Among them, 21 carried a specific genetic mutation, confirming the diagnosis. Affected individuals often develop skin rashes first, unlike other patients who typically start with fever. Other signs include cartilage inflammation, particularly in the nose and ears, as well as visible abnormalities in the bone marrow, where vacuoles appear in developing cells.
The study also revealed rare cases, such as kidney damage, strokes, or inflammation of the pulmonary arteries, thereby expanding the understanding of this disease. A new genetic mutation, never previously described, was identified in one patient, confirming the diversity of possible causes.
Researchers developed a screening tool based on the age of symptom onset, the presence of skin lesions, cartilage inflammation, anemia with abnormally large red blood cells, and vacuoles in the bone marrow. This tool, tested on French and Spanish cohorts, proved effective in identifying suspected cases with high precision.
Current treatments, such as corticosteroids or drugs specifically targeting inflammation, show varying results. Some patients respond well to innovative therapies, such as interleukin-6 inhibitors or JAK inhibitors, while others require more aggressive approaches, such as azacitidine, a drug used in certain blood cancers. However, severe infections, particularly pulmonary ones, remain a major risk during treatment, highlighting the importance of tailored management and close monitoring.
This advancement enables doctors to better recognize this complex disease and improve patient care, especially in regions where genetic testing is not easily accessible.
A rare inflammatory disease better understood thanks to a Chinese study A severe inflammatory disease primarily affecting adult men has just been more thoroughly described by Chinese researchers. This condition, characterized by widespread inflammation, rheumatic symptoms, and blood abnormalities, is distinguished by frequent skin lesions and a particular type of anemia.
Scientists analyzed 57 patients with unexplained inflammation and blood disorders. Among them, 21 carried a specific genetic mutation, confirming the diagnosis. Affected individuals often develop skin rashes first, unlike other patients who typically start with fever. Other signs include cartilage inflammation, particularly in the nose and ears, as well as visible abnormalities in the bone marrow, where vacuoles appear in developing cells.
The study also revealed rare cases, such as kidney damage, strokes, or inflammation of the pulmonary arteries, thereby expanding the understanding of this disease. A new genetic mutation, never previously described, was identified in one patient, confirming the diversity of possible causes.
Researchers developed a screening tool based on the age of symptom onset, the presence of skin lesions, cartilage inflammation, anemia with abnormally large red blood cells, and vacuoles in the bone marrow. This tool, tested on French and Spanish cohorts, proved effective in identifying suspected cases with high precision.
Current treatments, such as corticosteroids or drugs specifically targeting inflammation, show varying results. Some patients respond well to innovative therapies, such as interleukin-6 inhibitors or JAK inhibitors, while others require more aggressive approaches, such as azacitidine, a drug used in certain blood cancers. However, severe infections, particularly pulmonary ones, remain a major risk during treatment, highlighting the importance of tailored management and close monitoring.
This advancement enables doctors to better recognize this complex disease and improve patient care, especially in regions where genetic testing is not easily accessible.
Sources Used
Report Source
DOI: https://doi.org/10.1186/s13023-026-04380-9
Title: Clinical characteristics and a screening tool for VEXAS syndrome: a case-control study from China
Journal: Orphanet Journal of Rare Diseases
Publisher: Springer Science and Business Media LLC
Authors: Menghui Yao; Min Shen; Chengjin Huang; Yang Jiao; Yue Sha; Xianyong Jiang; Xiaoxi Yang; Jun Feng; Na Xu; Weiguo Zhu; Valentin Lacombe; Jose Manuel Mascaro; Juan I. Arostegui; Yun Zhang; Xuejun Zeng